Craneware (LON:CRW) Shares Pass Above 200-Day Moving Average - What's Next?

Key Points

• Craneware plc shares have surpassed their 200-day moving average, indicating a notable increase in stock price, trading as high as GBX 2,400 ($32.56).
• Analysts have initiated coverage with buy ratings and set price targets, with Berenberg Bank and Shore Capital targeting GBX 2,800 and GBX 2,650 respectively.
• The company maintains a debt-to-equity ratio of 12.22 and a market capitalization of £803.81 million, suggesting a focus on financial sustainability in healthcare solutions.

Shares of Craneware plc (LON:CRW - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2,016 ($27.35) and traded as high as GBX 2,400 ($32.56). Craneware shares last traded at GBX 2,270 ($30.79), with a volume of 67,055 shares traded.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CRW shares. Berenberg Bank started coverage on Craneware in a research note on Wednesday, July 16th. They set a "buy" rating and a GBX 2,800 price objective for the company. Shore Capital reiterated a "buy" rating and set a GBX 2,650 price objective on shares of Craneware in a research note on Wednesday, July 16th. Two investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of "Buy" and an average target price of GBX 2,725.

Craneware Stock Performance

The company has a debt-to-equity ratio of 12.22, a quick ratio of 1.00 and a current ratio of 0.63. The firm's 50 day moving average is GBX 2,275.63 and its 200-day moving average is GBX 2,016. The stock has a market capitalization of £803.81 million, a price-to-earnings ratio of 5,341.18 and a beta of 0.28.

Craneware Company Profile

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.